Skip to main content
Explore URMC

menu

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Research Question:
Does erlotinib treat patients with non-small cell lung cancer?

Basic Study Information

Purpose:
This phase III ALCHEMIST trial studies how well erlotinib hydrochloride compared to observation works in treating patients with stage IB-IIIA non-small cell lung cancer that has been completely removed by surgery. Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Location: Highland Hospital

Study Contact Information

Study Coordinator: Site Public Contact
Phone: (585) 341-8113

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search